Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.20692 | 49 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.08662 | 46 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.08411 | 46 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.01579 | 46 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.0358 | 46 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.28877 | 50 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.15617 | 46 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.05152 | 45 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.04315 | 45 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.06818 | 46 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.07463 | 46 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.04309 | 46 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.08127 | 46 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.08039 | 46 |